3,3’-디인돌릴메탄을 유효성분으로 함유하는 염증 질환의예방 및 치료용 조성물
    1.
    发明公开
    3,3’-디인돌릴메탄을 유효성분으로 함유하는 염증 질환의예방 및 치료용 조성물 无效
    包含3,3'-二氢吲哚的预防和治疗炎症疾病的组合物

    公开(公告)号:KR1020090042689A

    公开(公告)日:2009-04-30

    申请号:KR1020070108588

    申请日:2007-10-27

    Abstract: A pharmaceutical composition containing 3,3'-diindolylmethane is provided to inhibit expression of iNOS(inducible nitrogen oxide synthase) induced from LPS(lipopolysaccharide) and expression of COX-2(cyclooxygenase-2) induced from TAP by suppressing signal transmission of NF-kappaB(nuclear factor kappa B) and AP-1(activator protein 1). A pharmaceutical composition for treatment and prevention of inflammation disease comprises 0.1-50wt% of 3,3'-diindolylmethane represented by the formula 1 as an active ingredient. The inflammation disease is acute inflammation disease, rheumatic arthritis, gastritis, colitis, nephritis, hepatitis, cancer or degenerative disease. A health food has a formulation selected from the group consisting of powder, granule, refinement, capsule and drink.

    Abstract translation: 提供含有3,3'-二吲哚基甲烷的药物组合物,以抑制由LPS诱导的iNOS(诱导型氮氧化物合成酶)(脂多糖)和由TAP诱导的COX-2(环氧合酶-2)表达,抑制NF- kappaB(核因子κB)和AP-1(活化蛋白1)。 用于治疗和预防炎症疾病的药物组合物包含0.1-50wt%的由式1表示的3,3'-二吲哚基甲烷作为活性成分。 炎性疾病是急性炎症疾病,风湿性关节炎,胃炎,结肠炎,肾炎,肝炎,癌症或退行性疾病。 保健食品具有选自粉末,颗粒,精制,胶囊和饮料的制剂。

Patent Agency Ranking